See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Sept. 28, 2009

Epilepsy Gout Attacks Migraine

(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:

Epilepsy

This is study is for people aged 18 to 60 who have epilepsy. To qualify, you must be taking a stable dose of Dilantin (phenytoin).

The research site is in San Antonio, Texas.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/epilepsy.aspx.

-----

Gout Attacks

This study will evaluate an investigational drug for preventing acute gout flares. To qualify, you must be aged 18 to 80.

The research site is in DeLand, Fla.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/gout.aspx.

-----

Migraine

This study will test an investigational drug for migraines. Candidates must be aged 18 to 65 and have at least one migraine per month.

The research site is in Kenosha, Wisc.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/migraine.aspx.

-----

Copyright 2009ClinicalConnection.com. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.